Brecon appoints Charles Evans operations director
This article was originally published in Scrip
Brecon Pharmaceuticals, a supplier of commercial packaging and clinical trials supply services, has appointed Charles Evans director of operations. Mr Evans, who previously served as site director and head of supply chain for GE Healthcare takes charge of 220 staff and 15 commercial packaging lines.
You may also be interested in...
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.